Review of glioblastoma and systemic comorbidities
Glioblastoma (GBM) is a highly aggressive malignancy with a poor prognosis. Despite advanced molecular characterization, the traditional tumor-centric model ignores the patient’s systemic body condition, which significantly influences disease progression and therapeutic outcomes. This review aims to elucidate the inter...